{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:09Z","timestamp":1753891929394,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00312","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T05:05:55Z","timestamp":1583989555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study"],"prefix":"10.3389","volume":"10","author":[{"given":"Michael Jonathan","family":"Kucharczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Man Git","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzin","family":"Khosrow-Khavar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Bahoric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Souhami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Anidjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Probst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Chaddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Sargos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamim","family":"Niazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1200\/JCO.2019.37.15_suppl.5001","article-title":"Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for metastatic free survival (MFS) after radical prostatectomy (RP): update at 9 years of the GETUG-AFU 16 phase III randomized trial (NCT00423475)","volume":"37","author":"Christian Carrie","year":"2019","journal-title":"J Clin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.ijrobp.2018.08.052","article-title":"Short term androgen deprivation therapy without or with pelvic lymph node treatment added to prostate bed only salvage radiotherapy: the NRG Oncology\/RTOG 0534 SPPORT trial","volume":"102","author":"Pollack","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without antiandrogen therapy in recurrent prostate cancer","volume":"376","author":"Shipley","year":"2017","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1470-2045(15)70045-8","article-title":"High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01\/05 GICOR): a randomised, controlled, phase 3 trial","volume":"16","author":"Zapatero","year":"2015","journal-title":"Lancet Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0022-5347(17)49951-4","article-title":"External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy","volume":"132","author":"Ray","year":"1984","journal-title":"J Urol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0022-5347(17)39686-6","article-title":"Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results","volume":"144","author":"Paulson","year":"1990","journal-title":"J Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0022-5347(17)32507-7","article-title":"Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy","volume":"152","author":"Sgrignoli","year":"1994","journal-title":"J Urol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.eururo.2011.02.024","article-title":"Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis","volume":"59","author":"Briganti","year":"2011","journal-title":"Eur Urol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.eururo.2013.09.025","article-title":"Predicting survival of patients with node-positive prostate cancer following multimodal treatment","volume":"65","author":"Abdollah","year":"2014","journal-title":"Eur Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international cliniscal trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst."},{"key":"B12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","article-title":"US valuation of the EQ-5D health states: development and testing of the D1 valuation model","volume":"43","author":"Shaw","year":"2005","journal-title":"Med Care."},{"key":"B13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol."},{"unstructured":"ProgramCTE\n          Common Terminology Criteria for Adverse Events, Version 3.0.2006","key":"B15"},{"key":"B16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(05)67101-2","article-title":"Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)","volume":"366","author":"Bolla","year":"2005","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2307\/2530297","article-title":"One-sample multiple testing procedure for phase II clinical trials","volume":"38","author":"Fleming","year":"1982","journal-title":"Biometrics."},{"key":"B18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/sim.721","article-title":"Sample size tables for exact single-stage phase II designs","volume":"20","author":"A'hern","year":"2001","journal-title":"Stat Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/j.1464-410X.2007.06844.x","article-title":"Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council\/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy","volume":"99","author":"Parker","year":"2007","journal-title":"BJU Int."},{"unstructured":"RichaudP\n          Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer2008","key":"B20"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/bju.12623","article-title":"A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy \u2013 Adjuvant Versus Early Salvage (RAVES) trial","volume":"113","author":"Pearse","year":"2014","journal-title":"BJU Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e175230","DOI":"10.1001\/jamaoncol.2017.5230","article-title":"Comparison between adjuvant and early-salvage postprostatectomy radiotherapy for prostate cancer with adverse pathological features","volume":"4","author":"Hwang","year":"2018","journal-title":"JAMA Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.eururo.2014.05.011","article-title":"More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer","volume":"67","author":"Abdollah","year":"2015","journal-title":"Eur Urol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1200\/JCO.2016.67.9647","article-title":"Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy","volume":"34","author":"Tendulkar","year":"2016","journal-title":"J Clin Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta9260","article-title":"Indirect comparisons of competing interventions","volume":"9","author":"Glenny","year":"2005","journal-title":"Health Technol Assess."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1016\/j.ijrobp.2004.06.120","article-title":"A multi-institutional analysis of adjuvant and salvage radiotherapy after radical prostatectomy","volume":"60","author":"Pollack","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.eururo.2018.06.018","article-title":"Duration of androgen deprivation therapy in high-risk prostate cancer: a randomized phase III trial","volume":"74","author":"Nabid","year":"2018","journal-title":"Eur Urol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.ijrobp.2019.06.456","article-title":"A phase III multi-centre randomised trial comparing adjuvant versus early salvage radiotherapy following a radical prostatectomy: results of the TROG 08.03 and ANZUP RAVES trial","volume":"105","author":"Kneebone","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B31","doi-asserted-by":"publisher","first-page":"v851","DOI":"10.1093\/annonc\/mdz394.042","article-title":"Timing of radiotherapy (RT) after radical prostatectomy (RP): first results from the RADICALS RT randomised controlled trial (RCT) [NCT00541047]","volume":"30","author":"Parker","year":"2019","journal-title":"Ann Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"v851","DOI":"10.1093\/annonc\/mdz394.041","article-title":"Adjuvant or salvage radiotherapy for the treatment of localised prostate cancer? A prospectively planned aggregate data meta-analysis","volume":"30","author":"Vale","year":"2019","journal-title":"Ann Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1200\/JCO.2015.63.3529","article-title":"Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09\/10","volume":"33","author":"Ghadjar","year":"2015","journal-title":"J Clin Oncol."},{"unstructured":"TranP\n          Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy.2014","key":"B34"},{"key":"B35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1200\/JCO.2017.35.6_suppl.45","article-title":"Combined abiraterone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA) in biochemically-relapsing prostate cancer patients following prostatectomy: a phase I study of the GETUG\/GEP","volume":"35","author":"Supiot","year":"2017","journal-title":"J Clin Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1200\/JCO.2019.37.7_suppl.29","article-title":"Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): the STREAM trial","volume":"37","author":"Armstrong","year":"2019","journal-title":"J Clin Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"TPS5097","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS5097","article-title":"A phase II salvage trial of AR inhibition with ADT and apalutamide with radiation therapy followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (STARTAR)","volume":"37","author":"Zhang","year":"2019","journal-title":"J Clin Oncol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.09.027","article-title":"Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies","author":"Touijer","year":"2017","journal-title":"Eur Urol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1001\/jamaoncol.2015.4350","article-title":"Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer: data from patients in the control arm of the STAMPEDE trial","volume":"2","author":"James","year":"2016","journal-title":"JAMA Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.eururo.2018.04.017","article-title":"Impact of adjuvant radiotherapy in node-positive prostate cancer patients: the importance of patient selection","volume":"74","author":"Abdollah","year":"2018","journal-title":"Eur Urol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1200\/JCO.2017.35.6_suppl.153","article-title":"Estimating the incidence of oligorecurrent and potentially salvageable prostate cancer on 18F-Choline PET-CT: Screening phase of the STOMP randomized phase II trial","volume":"35","author":"Ost","year":"2017","journal-title":"J Clin Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.eururo.2018.10.044","article-title":"Nodal oligorecurrent prostate cancer: anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates","volume":"75","author":"De Bruycker","year":"2018","journal-title":"Eur Urol."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T05:05:58Z","timestamp":1583989558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":42,"alternative-id":["10.3389\/fonc.2020.00312"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00312","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"article-number":"312"}}